FDA Documents of Biogen U.S. Corporation
Biogen U.S. Corporation is an organization that has been audited by the FDA 6 times between 2015 and 2023 across all 2 sites.
Documents
FDA 483 Biogen U.S. Corporation, Durham | 2023
Out-of-stock
Issued on: Oct 17, 2023
Biologics Form 483
FDA 483 Biogen U.S. Corporation, Research Triangle Park | 2022
Out-of-stock
Issued on: Dec 9, 2022
Biologics Form 483
FDA 483 Biogen U.S. Corporation, Research Triangle Park | 2022
Out-of-stock
Issued on: Aug 26, 2022
Human Drug Form 483
FDA 483 Biogen U.S. Corporation, Research Triangle Park | 2022
Out-of-stock
Issued on: Aug 19, 2022
Human Drug Form 483
FDA 483 Biogen U.S. Corporation, Research Triangle Park | 2018
Out-of-stock
Issued on: May 4, 2018
Human Drug Form 483
FDA 483 Biogen U.S. Corporation, Research Triangle Park | 2015
Out-of-stock
Issued on: Dec 10, 2015
Human Drug Form 483
FDA Investigators(16)
- Gene D. Arcy, FDA Investigator
- Latorie S. Jones, FDA Investigator
- Prajakta A. Varadkar, FDA Investigator
- Gregory A. Price, FDA Investigator
- Alifiya H. Ghadiali, FDA Investigator
- Daniel Lagasse, FDA Investigator
- Veronica Fuentes, FDA Investigator
- Song Y. Lavalais, FDA Investigator
- Wendy G. Tan, FDA Investigator
- Esther C. Broner, FDA Investigator
- Viviana Matta, FDA Investigator
- Ephrem T. Hunde, FDA Investigator
- Sonya M. Edmonds, FDA Investigator
- Christopher S. Keating, FDA Investigator
- Seneca D. Toms, FDA Investigator
- Adam R. Cooke, FDA Investigator